Objectives: The aim of this study was to investigate the possible benefits from computed tomography scans of patients with a suspected pulmonary artery embolism with a focus on relevant extravascular findings. Methods: A total of 400 consecutive computed tomography pulmonary angiographies were evaluated. Computed tomography scans were analyzed in detail for the presence of pulmonary artery embolisms, as well as any other findings. Extra-artery discoveries were classified into none-relevant (Group A), intermediate (Group B), or relevant (Group C) findings. Results: Aggregated computed tomography pulmonary angiographies detected other diagnosis than pulmonary artery embolism in 236 patients (59%). There were 1950 non-pulmonary artery embolism findings (4.9 per patient; n ¼ 397). In the pulmonary artery embolism group, there were 447 extra-pulmonary artery embolism findings (5.2 per patient; n ¼ 86) and in the non-pulmonary artery embolism group, 1503 findings (4.8 per patient; n ¼ 311). Patients with pulmonary artery embolism had a significantly higher rate of pro-coagulate risk factors (p < 0.001). Conclusions: Computed tomography pulmonary angiographies may help to identify further diagnoses. This study represents a retrospective review of a single center experience for incidental computed tomography findings during pulmonary artery embolism work-up and emphasizes the importance of analyzing the whole field-of-view.
Introduction
Pulmonary embolism is a common and daily diagnosis in clinical routine today. 1 The indication for imaging and the usage of computed tomography (CT) is high in accordance with current guidelines and correct diagnostic pathways for pulmonary embolism. 2, 3 Generally, D-dimer analysis is performed after having completed physical examination, checked clinical symptoms, and patients' history in detail. 4, 5 Dyspnea, thoracic pain, syncope or shock could be caused by a pulmonary embolism or by other pathologies like the rupture of an arterial aneurysm, pulmonary infection or a tumor disease. [6] [7] [8] Even degenerative skeletal or (non-) metastatic diseases could provoke thoracic discomfort. Some of the patients are already under medication prior to the appearance in the emergency unit; thus, clinical signs could be concealed. As demonstrated in previous studies, a pulmonary embolism can result in different kinds of clinical signs and symptoms. But there is a prevalence of incidental findings (e.g. an infection) with similar appearance, which could be the fundamental reason for the presented symptoms. These findings could change patients' treatment and could have an influence on the final outcome and quality of life. [6] [7] [8] Additionally, it would be worthwhile to further characterize the embolisms (peripheral/central) or detect, if symptoms could be caused by other thoracic, abdominal or skeletal origins. 5 The purpose of this study was to determine the frequency and relevance of extra-focal adjacent findings in computed tomography pulmonary angiographies (CTPA) using a relatively large patient cohort (n ¼ 400) with consecutive CT scans including a common field-of-view (FOV). We planned to evaluate the current role of CT in patients with suspected pulmonary artery embolism (PAE).
Patients and methods

Patient's characteristics
For this retrospective study, patients were identified using the local digital patient database and radiological information system. A total of 400 consecutive CTPA during a 20-month period between March 2011 and November 2012 were evaluated retrospectively in a single center study using a 16-slice (Somatom Sensation 16; Siemens Healthcare, Erlangen, Germany) and a 64-slice (VCT Light Speed, GE Healthcare, Milwaukee, USA) CT. CT scans were analyzed in detail for the presence of pulmonary artery embolisms, as well as any other findings (e.g. cysts or calcification of vessels). Initial symptoms and underlying diseases were reported. Solely in relatively extreme emergency cases (previous cardio pulmonary reanimation by an emergency medical team, four cases in total) full anamnesis was not possible. Data sets (e.g. names, birth dates and reports) were blinded. Written informed consent was obtained from each patient for the CT scan and following clinical imaging and scientific analysis. The indication was made by the leading emergency medical specialist in consensus with the emergency radiologist. This study was in consensus with the Declaration of Helsinki and the local ethic committee approved this type of study.
CT protocol
The CT scan protocol depended on the clinical indications. All scans were performed because of a suspected pulmonary embolism. A typical protocol is described as the following: Before the imaging, all patients were animated to hyperventilate (if possible). Then, the scan was performed at maximum inspiration during a single breath-hold and extended from the lower cervical region (including lung apices) to the upper abdomen (including the diaphragm); thus, parts of the neck and upper abdomen were included in the FOV. The scan length ranged from 30 to 50 mm, depending on the individual patient's stature. For CT, 80 À 100 ml iodinated contrast agent (Imeron 350 or 400, Bracco Imaging, Konstanz, Germany) were injected into an ante cubital vein (e.g. 18-gauge) followed by a 40 ml saline flush, both at a flow rate of 4 ml/s (Medrad, Stellant, CT Injection System, Bayer Vital GmbH, Leverkusen, Germany). The scan was triggered by an automated bolus tracking system with a region-ofinterest placed in the trunk of the main pulmonary artery. The threshold level for triggering was achieved when the attenuation of the main pulmonary artery measured about 50 Hounsfield Units. Section thickness was 1.25 Â 1.0 mm and 0.625 Â 0.625 mm for the 16-and 64-section CT scanners, respectively. The scan parameters were exemplarily: Spiral scan, craniocaudal direction, pitch 0.18 À 0.22, detector collimation 64 Â 0.625 mm, gantry rotation time 350 ms, tube voltage 120 kV, maximum tube current 500 mA, and using tube current modulation. CT slices with a thickness of 0.625 mm were reconstructed for coronal and rotational views. Multiplan reconstructions were used routinely with 1 mm thickness. Typical radiation dose parameters were exemplarily a volume CT dose index (CTDIVOL) of 50 mGy and dose length product of about 400 À 750 mGy Â cm. With a conversion factor of 0.017 for the chest, the effective dose was about 6.8 À 12.8 mSv. All CTs were performed without retrospective or prospective electrocardiographic gating. The total scanning time was 10-20 s.
Image analysis
All CT images were reviewed independently by two experienced radiologists (J.M.S., J.M.). They were blinded to the patients' names. Disagreements were solved in consensus. Axial and multiplanar CT images were viewed in standard window settings (lung, soft tissue, and bone window) using a Picture Archiving and Communication System (PACS, Centricity Radiology RA 1000, GE Healthcare, Milwaukee, USA). First, all pulmonary artery CT findings were analyzed and recorded, e.g. central vs. peripheral embolism or no embolism. Secondly, extraartery CT findings were noted, including pulmonary, osseous, abdominal, soft tissue or other abnormalities. These extra-artery findings were classified into none-relevant (Group A), intermediate (Group B) or relevant (Group C) findings, in line with previous studies. [6] [7] [8] [9] [10] [11] [12] [13] [14] An extra-pulmonary-artery finding was classified as "relevant", if it would have changed the diagnosis and/or the therapy. Otherwise, an extra-pulmonaryartery finding was classified as "non-relevant". The follow-up period of the images lasted until March 2015, which means, depending on the time of the patient's CT scan, there was a minimum of 24 and a maximum of 48 months' follow-up period. The "relevant" findings included, e.g. newly detected cancer, enlarged lymph nodes of the size > 10 mm, severe lung emphysema, and others. The "non-relevant" findings included mild degenerative spine disease, small lymph nodes <10 mm, unspecific pulmonary scars, and others. The patient history was not checked for any available images for comparison. All CT scans had diagnostic image quality. The diagnosis of PAE based on a low-attenuating, non-enhancing filling defect in a primary-, secondary-, or tertiary-order main pulmonary artery or branch, 14 being either positive or negative for PAE. D-dimer assay results were requested and obtained by clinicians. Results of the test were expressed in milligrams per liter. A test result of less than 0.5 mg/l was defined to be negative and levels of at least 0.5 mg/l were set as positive or pathologic. D-dimer levels were used in conjunction with CT angiograms. However, the diagnosis of PAE depended only on the CT angiographic results and not on a pathologic D-dimer level. Statistical analysis was performed using PASW 18.0 (Predictive Analysis Software, SPSS Inc., IBM, Armonk, New York, USA), and p < 0.05 was defined as statistically significant. Chi-square test was used to compare groups.
Results
General results
Out of a group of 400 patients, the data from 397 patients (99.25%) with an age of 67.5 AE 16.6 years (207 male, 190 female) were evaluated. Three CT scans had to be excluded, because these patients were examined twice during the study time interval. They got a second CTA scans relatively short after the first one without additional information. As expected, patients with a PAE (n ¼ 86, 21.7%, Figure 1 ) had a significantly higher rate of pro-coagulate risk factors, such as cancer or a previous PAE (29% vs. 12%, p < 0.001). A total of 311 patients had no sign of a PAE (78.3%, Figures 2 to 5 ). The aggregate CTPA found support for a relevant diagnosis other than PAE in 236 patients (59.4%). Interestingly, only 85 patients (21.4%) without a PAE were already treated according to their underlying disease; further 55 patients (13.9%) had pulmonary, and 16 (4%) extra-pulmonary findings leading to a therapeutic consequence (change of diagnosis and/or therapy; Tables 1 to 6 ).
Pulmonary and non-pulmonary artery embolism findings
All findings can be differentiated into the PAE and non-PAE groups, as well as into underlying diseases and symptoms (Tables 1 to 6 ). The majority of the PAE were acute (79/86; 91.9%; single thrombus/embolus) and located in the left or right lower lobe (66/86; 76.7%). In total, there were 1950 findings, which means there were 4.9 findings per patient (n ¼ 397). In the PAE group, there were 447 extra-PAE findings (5.2 per patient; n ¼ 86), whereas in the non-PAE group, there were 1503 findings (4.8 per patient; n ¼ 311).
Furthermore, most mild thoracic aortic calcifications were found in the PAE group (26/86; 30.2% vs. 79/311; 25.4%), but severe calcifications were more often observed in the non-PAE group (46/311; 14.8% vs. 6/86; 7.0%). A dilatation of the pulmonary arteries was more frequent in the PAE group (6/86; 7.0% vs. 4/311; 1.3%). Signs of 
Correlations with D-dimers
D-dimers were measured in 268 (268/397; 67.5%) patients (mean 3.73 AE 5.10 SD, range 0.23-35 mg/l). 
Correlations with PAE (non-) relevant findings
Non-relevant extra-artery findings (Group A) were detected in 10 ( Furthermore, 25 (25/86; 29.1%) patients with PAE had a pro-coagulate risk factor, like an extrapulmonary tumor manifestation (10/86; 11.6%), a deep vein thrombosis (9/86; 0.5%) or a status after pulmonary embolism (6/86; 7.0%). In this subgroup, there was no patient with a specific lung cancer. In comparison, there were 38 (38/311; 12.3%) cases without PAE with a pro-coagulate risk factor, like an extra-pulmonary tumor manifestation (17/311; 5.5%), a pulmonary cancer (4/311; 1.3%), deep vein thrombosis (10/311; .2%) or a prior PAE (7/311; 2.3%).
Discussion
PAE imaging
While analyzing a CTPA with a suspicion of PAE, it could be important to correlate the patient's clinical history with the image results to achieve the most appropriate diagnosis and to categorize the severity level of each disease. [2] [3] [4] [5] 15 In our study, patients with PAE had a significantly higher rate of pro-coagulate risk factors, such as cancer or previous PAE (29.1% vs. 12.3%, p < 0.001).
The localization of each vessel narrowing plays an important role (e.g. localization of an embolus/thrombus or in the pulmonary trunk/central or peripheral). [2] [3] [4] [5] In our study, we were able to detect 86 (86/397; 21.7%) patients with PAE. The majority of the PAE were acute (79/86; 91.9%) and located in the left or right lower lobe (56/86; 65.1%).
D-dimer
In the literature, the sensitivity of D-dimer assays is reported to be around 95% with a specificity of 27%. 16, 17 In our study, 86 patients were diagnosed with a PAE. In this group, a D-dimer result was accessible in 58 (58/86; 67.4%) cases and positive in 56 patients (56/58; 96.6%) with only two negative cases (2/58; 3.4%), whereas in 311 patients without any sign of PAE 210 (210/311; 67.5%) D-dimer assays were measured. Here, D-dimer tests were positive in 202 (202/210; 96.2%) cases and negative in 8 (8/210; 3.8%) patients.
The average value of positive D-dimers in a subject with PAE was 6.19 AE 6.85 mg/l (range 0.23-32.06 mg/l) and 3.81 AE 6.49 mg/l (range 0.43-35 mg/l) in patients without PAE. A lower D-dimer level in patients without PAE is in line with former studies. 4, 5 In patients with relevant findings (Group C) Ddimer showed an average of 3.62 AE 5.30 mg/l (range 0.43-35 mg/l), which is higher than in patients with non-relevant or intermediate findings. A possible explanation is that severe diseases (e.g. pneumonia, tumor) have an influence on pro-coagulate factors.
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Incidental findings
An advantage of CT is its ability to depict other conditions that could mimic PAE, such as acute lung abscess, pneumomediastinum, pneumothorax, pneumonia, pericardial or pleural effusion, cardiovascular disease, aortic dissection, mediastinitis, mediastinal abscess, esophageal rupture, and malignancy or interstitial pulmonary fibrosis. 15 These conditions were reported in 11-70% of CT examinations, which were performed because of suspected PAE. 18, 19 Altogether, we detected 1950 findings (4.9 per patient; n ¼ 397). A total of 447 extra-PAE findings (5.2 per patient; n ¼ 86) were identified in the PAE group and, 1503 (4.8 per patient; n ¼ 311) within the non-PAE group. Contrast-enhanced CT, specifically 64-MDCT (multi-detector computed tomography), has become a first-line imaging tool in many clinics for the correct diagnosis of PAE, due to its high inter-observer agreement, 20 identification of unsuspected pathologies, 21 and cost-effectiveness. 22 In patients with suspected PAE, extra-pulmonary artery findings may also be detected in a CT scan and these findings may just as well be the reason for their clinical presentation. 15 These findings can be non-relevant (e.g. a cyst or mild degenerative spine disease) or relevant, like a tumor or a treatable infection (e.g. pneumonia) and could change the patient's treatment, as well as the clinical outcome. [6] [7] [8] 
Study limitations
Our study was limited by the fact that it was evaluated retrospectively in a single center study without comparison to a gold standard. All images were evaluated on 16-or 64-slice CTs. No calculation was made to compare CT scanner modalities, image qualities or rate of findings. It would have been difficult in terms of radiation dosage and ethical concerns to scan patients twice with different techniques. The interobserver variability was not calculated in this study, because differences were directly cleared by consensus. Unfortunately, the emergency team changed every day, thus the decision for indication to perform a CTA scan with a suspicion of pulmonary embolism could vary individually (although knowing the guidelines). We did a follow-up period for the final imaging diagnosis, not for longterm morbidity or mortality of each patient, and this was not analyzed in this primarily imaging study. Our follow-up definition simply included the final diagnosis of a finding, if available.
Conclusions
This study demonstrates that a CT-scan of a patient with suspected PAE has to be thoroughly evaluated for pulmonary artery embolisms, as well as any other possible findings. There were 1503 findings in non-PAE patients (4.8 per patient; n ¼ 311). CTPA should be used in cases with suspected PAE, since a PAE was confirmed in 22% of all subjects. Additionally, CTPA helps clinicians to establish an alternative diagnosis. This study represents a retrospective review of a single center experience for incidental CT findings during PAE work-up and emphasizes the importance of analyzing the whole field-of-view. Before image analysis sufficient training should be performed by every physician. Patients with a PAE had a significantly higher rate of pro-coagulate risk factors than patients without PAE.
